Nasdaq

ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Clorazepate Dipotassium Tablets USP

BAUDETTE, Minn.--(BUSINESS WIRE)-- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that the Company received U.S. Food and Drug Administration (FDA) approval for the ...
Nasdaq

ANI Pharmaceuticals Says FDA Oks ANDA For Clorazepate Dipotassium Tablets

(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) announced Wednesday that it has received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Clorazepate ...
Healio

FDA approves abbreviated new drug application for oral anxiety treatment

Please provide your email address to receive an email when new articles are posted on . ANI Pharmaceuticals Inc. has received FDA approval of its abbreviated new drug application for clorazepate ...